Edition:
United Kingdom

Cyanotech Corp (CYAN.OQ)

CYAN.OQ on NASDAQ Stock Exchange Capital Market

3.30USD
9:00pm BST
Change (% chg)

$-0.08 (-2.37%)
Prev Close
$3.38
Open
$3.47
Day's High
$3.47
Day's Low
$3.30
Volume
1,160
Avg. Vol
1,236
52-wk High
$4.35
52-wk Low
$3.00

Summary

Name Age Since Current Position

Michael Davis

65 2011 Independent Chairman of the Board

Mawae Morton

52 2018 President, Chief Executive Officer, Director

Gerald Cysewski

69 2018 Vice Chairman of the Board, Chief Scientific Officer

Brian Orlopp

2019 Chief Financial Officer, Vice President of Finance and Administration, Secretary

Glenn Jensen

60 2015 Vice President - Manufacturing and Infrastructure

Jennifer Johansen

45 2009 Vice President - Quality & Regulatory Affairs

Nancy Katz

59 2016 Independent Director

Walter Menzel

71 2013 Independent Director

David Mulder

57 2016 Independent Director

David Vied

57 2015 Independent Director

Bruce Russell

Investor Relations Officer

Biographies

Name Description

Michael Davis

Mr. Michael A. Davis, M.D., is an Independent Chairman of the Board of Cyanotech Corp since April 13, 2011. Mr. Davis was appointed to the Board of Directors of the Company in March 2003. For over 30 years, Mr. Davis has been active as a private investor specializing in investments in natural and organic foods, nutraceuticals and the agriculture from which they are derived. He is President of Skywords Family Foundation and a Director of Canobie Films, Inc., and attended Harvard University. His business and investment experiences, as well as his long association with the Company provide the Board with critical perspective on the business issues the Company faces. Mr. Davis serves as Chairman of the Nominating and Corporate Governance Committee.

Mawae Morton

Mr. Mawae Morton is President, Chief Executive Officer, Director of the company. Mr. Morton has served as a strategic consultant to the Company since January 1, 2017, and as the President of the Company since July 14, 2017. Prior to that, he was the Chief Executive Officer of HBE BiorefineryCo, a Hawaii based forestry and bioenergy development company, and President of Matariki Group LLC, which provides consulting services for project development with a focus on renewable energy, forestry, agribusiness and environmental planning. Mr. Morton has also served as the Strategic Resource Manager for Kamehameha Schools, the largest land owner in Hawaii, and Managing Director at Merica International, a privately-owned group of companies with global interests in the renewable energy sector. Prior to that, Mr. Morton was a Senior Consultant with KPMG Consulting with projects in New Zealand, China, Singapore, Japan, and Silicon Valley, California. Mr. Morton holds a Master’s degree in Public Policy from Victoria University of Wellington and a Bachelor’s degree in agriculture from Massy University, in New Zealand.

Gerald Cysewski

Dr. Gerald R. Cysewski, Ph. D. is Vice Chairman of the Board, Chief Scientific Officer of the Company. He was became President and Chief Executive Officer as of August 25, 2016, after having served as Interim President and Chief Executive Office beginning March 31, 2016. Prior to this he was Executive Vice President and Chief Scientific Officer. Dr. Cysewski co-founded the Company in 1983 and has served as a director of the Company since that time. From 1990 to May 16, 2008, Dr. Cysewski served as the Company’s President and Chief Executive Officer, as well as Chairman of the Board. Prior to 1990, Dr. Cysewski served in various other capacities for the Company including Vice Chairman and Scientific Director. From 1980 to 1982, Dr. Cysewski was Group Leader of Microalgae Research and Development at Battelle Northwest, a major contract research and development firm. From 1976 to 1980, Dr. Cysewski was an assistant professor in the Department of Chemical and Nuclear Engineering at the University of California, Santa Barbara, where he received a two-year grant from the National Science Foundation to develop a culture system for blue-green algae. Dr. Cysewski received his doctorate in Chemical Engineering from the University of California at Berkeley. Dr. Cysewski continues to be recognized as a leading authority on large scale production of micro-algae and is a frequently invited speaker at industry gatherings around the world, providing insight to the Board on changes in micro-algae science and regulatory matters that impact the Company. His extensive experience with the Company and his expertise in micro-algae production make him uniquely qualified to serve on our Board.

Brian Orlopp

Mr. Brian Orlopp is Chief Financial Officer, Vice President of Finance and Administration, Secretary of the Company. Mr. Orlopp was VP-Finance, Asia Pacific from 2012 for Fresh Del Monte Produce based in Manila. Previously, he was CFO for Sumifru Corporation (joint venture with Sumitomo) based in Singapore. Before that, he was Senior VP/Finance for Hawaii Bioenergy LLC in Honolulu and VP/Strategic Planning for Maui Land & Pineapple Company in Kahului. He began his career working in varied financial management positions for Dole. His education includes degrees in Agriculture Economics, General Management and Finance.

Glenn Jensen

Mr. Glenn D. Jensen is Vice President - Manufacturing and Infrastructure of Cyanotech Corp. From 1993 to 2015, he served as Vice President of Operations. Mr. Jensen joined the Company in 1984 as Process Manager. Mr. Jensen has 35 years’ experience in microalgae process operations. Prior to joining the Company, Mr. Jensen worked as a plant engineer at Cal-Alga, a spirulina production facility, near Fresno, California. Mr. Jensen holds a B. S. degree in Health Science from California State University, Fresno.

Jennifer Johansen

Ms. Jennifer M. Johansen is Vice President - Quality & Regulatory Affairs of Cyanotech Corp. Ms. Johansen joined Cyanotech in 2003 in the Quality Department and has 14 years of experience in quality and regulatory. Prior to joining the Company, Ms. Johansen worked in medical research at the University of Washington. Since 2012, Ms. Johansen has been working alongside the United Natural Products Alliance (UNPA) to develop the next generation of congressional champions for the Dietary Supplement and Natural Products industry. Ms. Johansen is the Chairwoman for the Hawaii State Chapter of UNPA and is on the Kona Kohala Chamber of Commerce Economic Development Committee and Sustainability Committee. Ms. Johansen holds a degree in Psychology, with a minor in Organic Chemistry, from the University of Oregon while on a full athletic scholarship.

Nancy Katz

Ms. Nancy E. Katz serves as Independent Director of the Company. Ms. Katz served as Vice President, Consumer Marketing at Medtronic, Inc., a medical technology company, from May 2011 to August 2014. From July 2005 to July 2010, Ms. Katz was Senior Vice President, Bayer Diabetes Care — North America. Prior to this position, she was President and Chief Executive Officer of Calypte Biomedical Corporation, a manufacturer of HIV diagnostics, President of Zila Pharmaceutical, Inc., a manufacturer of oral care products, and held senior marketing positions with the Lifescan division of Johnson & Johnson (blood glucose diabetes products), Schering-Plough Healthcare Products, and with American Home Products. Ms. Katz has previously served on the Boards of Directors of Neoprobe Corporation, Calypte Biomedical Corporation, LXN Corporation and Pepgen Corporation. Ms. Katz currently serves on the Board of NeuroMetrix, Inc. Ms. Katz received a B.S. in business from the University of South Florida. Ms. Katz has significant experience as an executive and director of public companies and provides valuable insight to the Board and management in strategy development and other Company functions. Ms. Katz is a member of the Audit Committee and the Nominating and Corporate Governance Committee.

Walter Menzel

Mr. Walter B. Menzel is Independent Director of the Company in August 2013. Mr. Menzel is the President of the WM Group, a contract provider of management, marketing, and creative services for established and entrepreneurial enterprises and organizations. In addition, he is CEO of the Peter Michael Foundation, an underwriter of cancer research at leading medical centers. Mr. Menzel is also Co-Founder of Prostate Management Diagnostics Inc., a private company in partnership with The Genome Institute at Washington University in St. Louis. Previously, he was Senior VP at McCann-Erickson, and served in positions of increasing client services responsibility at BBDO West, Needham Harper Worldwide, Leo Burnett Company, and J. Walter Thompson Company. Mr. Menzel is a graduate of the University of Wisconsin (BA) and Stanford University (MBA and MA) and is a National Association of Corporate Directors Board Leadership Fellow. His extensive experience and expertise in branding and marketing provides a unique perspective and contribution to the Board. Mr. Menzel serves as Chairman of the Compensation Committee and is a member of the Audit Committee.

David Mulder

Mr. David M. Mulder is an Independent Director of the company. Mr. Mulder is Executive Vice President and Chief Financial Officer of Reiter Affiliated Companies, where he has served since December of 2012. He also serves as the Chairman of the Board of FreSeguro, Inc., a Hawaiian captive insurance company. Mulder has over 25 years of international financial and general management experience in a broad variety of businesses, including agriculture, consumer products, wholesale products, distribution and medical products. His background includes serving as the CEO of Biolase, a public international medical device company, and as the CFO of Salton as the (then) public company doubled in size during the globalization of the George Foreman grill. He built his early career at Fruit of the Loom, where he last served as the head of the European, Middle East and Africa division. He started his professional career at Arthur Andersen where he did both consulting and audit, earning his CPA. He earned his Masters of Business Administration degree from the Fuqua School of Business at Duke University. His financial and accounting background, as well as his leadership experiences, are critical to the Company’s long range goals. Mr. Mulder serves as Chairman of the Audit Committee.

David Vied

Mr. David L. Vied is an Independent Director of the Company. Mr. Vied was elected to the Board on January 27, 2015. Mr. Vied serves as the Global Sector Leader, Medical Devices & Diagnostics for Korn Ferry, a global leadership and talent advisory firm. Previous experience includes serving in leadership roles for other global recruiting and talent advisory firms. Mr. Vied received a B.A. degree in Communication Studies from California State University at Sacramento and a M.S. degree in Labor and Industrial Relations from the University of North Texas. His experience in management and corporate organization rounds out an important expertise represented on the Board. Mr. Vied is a member of the Nominating and Corporate Governance Committee and the Compensation Committee.

Bruce Russell

Basic Compensation